Invention Grant
- Patent Title: Histone demethylase inhibitors
-
Application No.: US15446996Application Date: 2017-03-01
-
Publication No.: US10040779B2Publication Date: 2018-08-07
- Inventor: Toufike Kanouni , Jeffrey Alan Stafford , James Marvin Veal , Michael Brennan Wallace
- Applicant: CELGENE QUANTICEL RESEARCH, INC.
- Applicant Address: US CA San Diego
- Assignee: Celgene Quanticel Research, Inc.
- Current Assignee: Celgene Quanticel Research, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Wiley Rein LLP
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D401/12 ; C07D413/12 ; C07D405/14 ; C07D413/14

Abstract:
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted 3-aminopyridine derivative compounds, substituted 3-aminopyridazine derivative compounds, and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
Public/Granted literature
- US20170174656A1 HISTONE DEMETHYLASE INHIBITORS Public/Granted day:2017-06-22
Information query